OR5AN1: The Olfactory Receptor 5AN1: A Potential Drug Target and Biomarker
OR5AN1: The Olfactory Receptor 5AN1: A Potential Drug Target and Biomarker
Smell is a crucial sense that many animals use to identify and remember important events, such as food, danger, and the presence of other individuals. The olfactory system, which is responsible for processing and interpreting smells, is a complex sensory organ that links the brain and the rest of the body. One of the proteins that are involved in this system is OR5AN1, which is a transmembrane protein that is expressed in the sensory neurons of the olfactory system.
OR5AN1 is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a key role in sensory signaling. GPCR family proteins are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and behavior. OR5AN1 is specifically involved in the sense of smell, and its function is not well understood.
Recent studies have identified OR5AN1 as a potential drug target and biomarker for a variety of neurological and psychiatric disorders. Its function in the olfactory system has been implicated in the development and progression of several disorders, including Alzheimer's disease, Parkinson's disease, and anxiety disorders.
One of the key factors that has made OR5AN1 an attractive drug target is its high expression level in the brain. Studies have shown that OR5AN1 is highly expressed in the brain and that it is involved in the development and progression of neurodegenerative disorders. This suggests that targeting OR5AN1 with drugs could be an effective way to treat these disorders.
In addition to its potential therapeutic uses, OR5AN1 is also a potential biomarker for several neurological disorders. Its expression has been implicated in the development of Alzheimer's disease, and studies have shown that targeting OR5AN1 with drugs could be an effective way to diagnose and treat this disorder. Similarly, OR5AN1 has also been shown to be involved in the development and progression of Parkinson's disease, and targeting it with drugs could be an effective way to treat this disorder.
Another promising aspect of OR5AN1 is its involvement in the regulation of pain and inflammation. Studies have shown that OR5AN1 is involved in the regulation of pain signaling and that it is involved in the regulation of inflammation. This suggests that targeting OR5AN1 with drugs could be an Effective way to treat chronic pain and inflammation disorders.
In conclusion, OR5AN1 is a protein that is involved in the olfactory system and has been shown to be involved in the development and progression of several neurological and psychiatric disorders. Its high expression level in the brain and its potential as a drug target and biomarker make it an attractive target for research into the treatment of these disorders. Further studies are needed to fully understand the role of OR5AN1 in the olfactory system and its potential as a drug and biomarker.
Protein Name: Olfactory Receptor Family 5 Subfamily AN Member 1
Functions: Odorant receptor involved in the detection of muscone, cyclopentadecanone, cyclopentadecanol, and omega-pentadecalactone (PubMed:24361078, PubMed:25901328). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (Probable)
The "OR5AN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5AN1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P
